Novara for perimenopause

Perimenopause represents the transitional phase preceding menopause as ovarian estrogen production progressively declines. Onset commonly occurs during the 40s, though earlier initiation is possible. Manifestations encompass cycle irregularity, thermal episodes, sleep disturbances, and emotional variations. This phase concludes following 12 consecutive months of absent menstruation (menopause).

HRT is most appropriate for women with moderate to severe perimenopause symptoms that affect quality of life. Our physicians evaluate your symptoms, health history, and risk factors to determine if HRT is a good fit. For most healthy women under 60 or within 10 years of menopause, the benefits outweigh the risks.

Novara™ employs bioidentical hormones (molecularly matching your natural compounds) delivered transdermally. Unlike synthetic alternatives or oral formulations, this approach yields steadier hormonal concentrations, avoids hepatic processing, and generally produces fewer complications. Additionally, your dosage undergoes individualization according to symptom presentation.

Many women notice improvements in sleep and mood within the first 1-2 weeks. Hot flashes and night sweats typically improve within 2-4 weeks. Full benefits are usually felt by 4-8 weeks. We'll check in with you regularly and can adjust your treatment if needed.

For most healthy women, yes. The latest research shows that for women under 60 or within 10 years of menopause, the benefits of HRT typically outweigh the risks. Transdermal delivery (like Novara™) has a better safety profile than oral hormones. Our physicians carefully evaluate your individual risk factors before prescribing.

If you don't see improvement after 8 weeks, we'll work with you to adjust your treatment — whether that means changing your dose, trying a different formulation, or exploring other options. You can cancel anytime, and we offer a satisfaction guarantee for your first month.